- Allergy and Immunology
- Cardiovascular Disease
- Digestive Diseases and Nutrition
- Emergency Medicine
- Endocrinology and Metabolism
- Ethics, Humanities & Palliative Medicine
- Evidence Based Medicine & Health Outcomes
- General Internal Medicine
- Geriatric Medicine
- Hematology and Medical Oncology
- Infectious Diseases and International Medicine
- Hospital Medicine
- Nephrology and Hypertension
- Preventative and Occupational Medicine
- Pulmonary, Critical Care, and Sleep Medicine
- Rheumatology
- Translational Medicine
Sally Alrabaa, MD
Fellowship, Infectious Disease and Inernational Medicine, USF College of Medicine, Tampa, Florida
Residency, Internal Medicine, St. Vincent's Medical Center, New York
MBBS, University of Khartoum, Sudan
Phone: (813) 844-4187
Biographical Sketch
Dr. Alrabaa is an Assistant Professor in the Division of Infectious Disease and International Medicine at the University of South Florida. Dr. Alrabaa received her medical degree from the University of Kartoum in Sudan, completed her internal medicine residency at Saint Vincent Hospital (affiliated with new York Medical College), and completed her infectious disease fellowship at the University of South Florida.
Dr. Alrabaa is also affiliated with the Hillsborough County Health Department as a supervising attending physician in the Specialty Care Clinic and as an investigator in the Clinical Research Unit.
Areas of Expertise
Infections in transplant recipients, healthcare associated infections, travel related infections, and HIV/AIDS.
Current Research
Alrabaa S. Merck MK 3415-002. A pilot, randomized, controlled study to evaluate the safety and efficacy of antitoxin A and B in Clostridium difficile associated diarrhea. Tampa, FL, 2012 - present
Alrabaa S, Greene J. Interferon gamma the treatment of disseminated mycobacterium abscesses infection in leukemic patients. H. Lee Moffitt Cancer Center, Tampa, 11/2010
Alrabaa S, Greene J. Alpha interferon in the treatment of RSV pneumonia in bone marrow transplant recipients; improved morbidity and mortality. H. Lee Moffitt Cancer Center, Tampa, 1/2009 – 10/2009 [Abstract presented at IDSA Annual Meeting, 10/2009]
Publications/Presentations
Alrabaa S, Nguyen P, Sanderson R, Baluch A, Sandin R, Kelker D, Karlapalem C, Thompson P, Sams K, Martin S, Montero J, Greene J. Early identification and control of carbapenemase-producing Klebsiella penumoniae, originating from contaminated endoscopic equipment. American Journal of Infection Control (AJIC), 2013, in press
Pham T, Alrabaa S, Somboonwit C, Hung L, Montero J. The HIV virologic outcomes of different interventions among treatment-experienced patients with 2 consecutive detectable low-level viremia. J Int Assoc Physicians AIDS Care (Chic). 2011 Jan-Feb; 10(1):54-6. University of South Florida, College of Medicine, Tampa, FL, USA. Available online.
Alrabaa S, Greene J. Alpha interferon in the treatment of RSV pneumonia in bone marrow transplant recipients, improved morbidity and mortality. Presented at: Infectious Disease Society of America (IDSA) Annual Meeting, Oct. 2009, Philadelphia, PA
Alrabaa S, Greene J. Fluoroquinolone resistance among leukemic patients receiving fluoroquinolone prophylaxis, increased incidence but improved overall morbidity, IDSA Annual Meeting, Oct 2009, Philadelphia, PA
Wills T, Sinnott JT, Alrabaa S. Viral Hemorrhagic Fevers. APIC Text of Infection Control and Epidemiology, 3rd ed. Association for Professionals in Infection Control and Applied Epidemiology Principles and Practice (APIC). Washington, 2009